skip to main content

MART regimen counselling — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory TherapeuticsMART regimen counsellingGPhC CRA

A discharge prescription labels fluticasone/salmeterol 250/50 as “one inhalation twice daily and one additional inhalation when breathless as MART”. The patient has no separate reliever. What should the pharmacist do?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AAsk the prescribing team to correct the MART reliever plan

MART uses a combination containing formoterol because its rapid onset permits reliever use. Fluticasone/salmeterol is maintenance treatment and is not a MART reliever. The prescribing discrepancy must be corrected before discharge so the patient has an effective rescue plan and a clear maintenance regimen; the pharmacist should not unilaterally substitute active ingredients.

Reference: NICE NG245, Asthma diagnosis, monitoring and chronic management: https://www.nice.org.uk/guidance/ng245/chapter/Recommendations